This is a preview of subscription content, log in via an institution to check access.
References
Sisson, J.C., Frager, M.X., Valk, T.W.: Scintigraphic localization of pheochromocytoma. N. Engl. J. Med.305:12, 1987
Valk, T.W., Frager, M.S., Gross, M.D., Sisson, J.C., Wieland, D.M., Swanson, D.P., Mangner, T.J., Beierwaltes, W.H.: Spectrum of pheochromocytoma in multiple endocrine neoplasia. Ann. Intern. Med.94:762, 1981
Shapiro, B., Sisson, J.C., Copp, E.J.E., Dmuchowski, C., Beierwaltes, W.H.:131I-MIBG: A new agent in diagnosis and treatment of pheochromocytoma. Cardiology72[Suppl.]:127, 1985
Francis, I.R., Glazer, G.M., Shapiro, B., Sisson, J.C., Gross, B.H.: Complementary roles of CT and131I-MIBG scintigraphy in diagnosing pheochromocytoma. Am. J. Radiol.141:719, 1983
Shapiro, B., Copp, J.E., Sisson, J.C., Eyre, P.L., Wallis, J., Beierwaltes, W.H.: Iodine-131 metaiodobenzylguanidine for the location of suspected pheochromocytoma: Experience in 400 cases. J. Nucl. Med.26:576, 1985
Shapiro, B.: MIBG in the diagnosis and therapy of neuroblastoma and pheochromocytoma. In Proceedings of the International Symposium of Recent Advances in Nuclear Medicine, Udine, Italy, October, 1987
Swensen, S.J., Brown, M.L., Sheps, S.G.: Use of131I-MIBG scintigraphy in the evolution of suspected pheochromocytoma. Mayo Clin. Proc.60:299, 1985
Chatal, J.F., Charbonnel, B.: Comparison of iodobenzylguanidine imaging with computed tomography in locating pheochromocytoma. J. Clin. Endocrinol. Metab.61:769, 1985
Hoefnagel, C.A., Vaute, P.A., DeKraker, J.: Radionuclide diagnosis and therapy of neural crest tumors using I131 meta-iodobenzylguanidine. J. Nucl. Med.28:308, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scott, H.W. Invited commentary. World J. Surg. 12, 550–551 (1988). https://doi.org/10.1007/BF01655448
Issue Date:
DOI: https://doi.org/10.1007/BF01655448